Indications for Liver Transplantation
Liver transplantation should be considered in any patient with end-stage liver disease when expected survival without transplant is one year or less, or when the patient has unacceptable quality of life due to liver disease. 1
Primary Indication Categories
The three main indication categories for liver transplantation are:
1. End-Stage Chronic Liver Disease (Cirrhosis)
This represents the most common indication for liver transplantation in adults 1. Patients should be referred to transplant centers when major complications of cirrhosis develop, including:
- Variceal hemorrhage
- Ascites
- Hepatorenal syndrome
- Hepatic encephalopathy 1
The specific etiologies have evolved significantly. While hepatitis C virus was historically dominant, effective antiviral therapies have caused deep, sustained declines in HCV-related cirrhosis as an indication 2. Currently, the fastest-growing indications are:
- Metabolic dysfunction-associated steatohepatitis (MASLD/MASH)
- Alcohol-related liver disease (including patients with brief periods of sobriety) 2
2. Hepatocellular Carcinoma (HCC)
HCC represents a major indication for transplantation, accounting for 38% of transplants in some centers 3. This indication has expanded over time with refined selection criteria 4.
3. Acute Liver Failure
This represents an urgent indication for liver transplantation 1. The most common causes include:
- Viral hepatitis (especially hepatitis A and B)
- Acetaminophen toxicity
- Other drugs and toxic agents
- Seronegative hepatitis (most common cause in the UK) 1
Prognosis is determined primarily by neurological status and multi-organ damage. Liver transplantation has revolutionized outcomes, increasing survival from 10-20% to 75-80% at 1 year and 70% at 5 years 1.
Expanded and Emerging Indications
Recent advances have led to consideration of conditions previously deemed contraindications 4:
Metabolic and Genetic Disorders
Various metabolic and genetic conditions now qualify for transplantation 5.
Budd-Chiari Syndrome
Patient selection must be individualized considering alternative therapeutic options (transjugular intrahepatic portosystemic shunts, surgical shunts) 6. Best results occur in patients with:
- Thrombosis limited to hepatic veins
- Underlying cause correctable by liver replacement 6
Patients with underlying malignancy or combined hepatic and portal vein thrombosis have worse outcomes 6.
Polycystic Liver Disease
Liver transplantation is occasionally indicated for patients severely debilitated by abdominal pain, anorexia, or fatigue, though liver failure is uncommon 6. These patients experience dramatic symptom improvement but are unusually susceptible to post-transplant infection 6.
Metastatic Neuroendocrine Tumors
Transplantation should be confined to highly selected patients who meet all of the following:
- Not candidates for surgical resection
- Tumors not accessible to curative surgery or major tumor reduction
- Tumors not responding to medical or interventional treatment
- Life-threatening hormonal symptoms persisting despite optimal medical therapy 6
Outcomes have been mixed, with most patients dying of recurrent disease within the first few years, though occasional long-term disease-free survivors exist 6.
Retransplantation
This accounts for approximately 10% of all liver transplants 6. Most frequent indications include:
- Primary graft nonfunction
- Hepatic artery thrombosis
- Allograft rejection
- Recurrent disease 6
Poor prognostic factors include:
- Urgent retransplantation
- MELD score >25
- Child-Turcotte-Pugh score ≥10
- Elevated serum bilirubin and creatinine 6
Retransplantation for recurrent hepatitis C has particularly poor survival 6.
Critical Timing Considerations
The fundamental principle is that predicted mortality without transplantation must exceed mortality with transplantation, coupled with a predicted 5-year survival following transplant of at least 50% 7. The risk posed by liver disease must be weighed against transplant risks, considering comorbidities, age, nutritional status, and behavioral factors 7.
Important Caveats
- MELD score-based allocation does not serve all indications equally 2, particularly for conditions like HCC where disease severity may not correlate with MELD score
- Geographic disparity in access to transplantation exists despite increases in donor organs 2
- Organ shortage remains the primary limiting factor, with waiting times around one year in some regions 5
- Meticulous patient selection and timing are crucial to optimize individual outcomes while responsibly using the limited donor pool 8